Trial Profile
This phase I, prospective, two period, fixed sequence study will investigate the pharmacokinetics (PK), glucodynamics (GD), safety, and tolerability of Insulin peglispro [LY2605541] in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Insulin peglispro (Primary) ; Insulin peglispro
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Eli Lilly and Company
- 09 Dec 2015 New trial record